Cargando…
Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinoma
Nab‐paclitaxel (Abraxane), which is a nanoparticle form of albumin‐bound paclitaxel, is one of the standard chemotherapies for pancreatic ductal adenocarcinoma (PDAC). This study determined the effect of Abraxane in combination with a fusion protein, hIL15‐ABD, on subcutaneous Panc02 and orthotopic...
Autores principales: | Hsu, Fei‐Ting, Tsai, Chang Liang, Chiang, I‐Tsang, Lan, Keng‐Hsueh, Yueh, Po‐Fu, Liang, Wen‐Yi, Lin, Chi‐Shuo, Chao, Yee, Lan, Keng‐Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980892/ https://www.ncbi.nlm.nih.gov/pubmed/35174623 http://dx.doi.org/10.1111/jcmm.17220 |
Ejemplares similares
-
Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma
por: Hsu, Fei-Ting, et al.
Publicado: (2021) -
Albumin-bound formulation of paclitaxel (Abraxane(®) ABI-007) in the treatment of breast cancer
por: Miele, Evelina, et al.
Publicado: (2009) -
nab-Paclitaxel (Abraxane(®)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors
por: Iglesias, J
Publicado: (2009) -
Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model
por: Li, Weiwei, et al.
Publicado: (2022) -
Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System
por: Chen, Yen-Ju, et al.
Publicado: (2020)